![Lindsey Rolfe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lindsey Rolfe
Directeur Technique/Scientifique/R&D chez
3B Pharmaceuticals GmbH
Fortune : - $ au 31/08/2026
Profil
Lindsey Rolfe is currently an Independent Director at CERo Therapeutics Holdings, Inc. since 2024 and Chief Medical Officer at 3B Pharmaceuticals GmbH since 2023.
Former roles include Independent Director at Atreca, Inc. from 2019 to 2024, Member of The Royal College of Physicians, and Chief Medical Officer & Executive VP-Clinical at Clovis Oncology, Inc. from 2015 to 2023.
Education includes a doctorate from The University of Edinburgh.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 28/04/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Lindsey Rolfe
| Sociétés | Poste | Début |
|---|---|---|
3B Pharmaceuticals GmbH
 3B Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Researches and develops radiopharmaceutical drugs and diagnostics for oncology indications | Directeur Technique/Scientifique/R&D | 01/08/2023 |
Anciens postes connus de Lindsey Rolfe
| Sociétés | Poste | Fin |
|---|---|---|
| ATRECA, INC. | Directeur/Membre du Conseil | 01/05/2024 |
| CLOVIS ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | 01/06/2023 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Lindsey Rolfe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Atreca, Inc.
 Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
3B Pharmaceuticals GmbH
3B Pharmaceuticals GmbH Miscellaneous Commercial ServicesCommercial Services Researches and develops radiopharmaceutical drugs and diagnostics for oncology indications | Commercial Services |
